<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MD</journal-id>
<journal-title>Marine Drugs</journal-title>
<abbrev-journal-title>MD</abbrev-journal-title>
<issn pub-type="epub">1660-3397</issn>
<publisher>
<publisher-name>Molecular Diversity Preservation International</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3390/md9020162</article-id>
<article-id pub-id-type="publisher-id">marinedrugs-09-00162</article-id>
<article-categories>
<subj-group>
<subject>Article</subject></subj-group></article-categories>
<title-group>
<article-title>New Cytotoxic Oxygenated Sterols from the Marine Bryozoan <italic>Cryptosula pallasiana</italic></article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Tian</surname><given-names>Xiang-Rong</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-00162"><sup>1</sup></xref><xref ref-type="aff" rid="af2-marinedrugs-09-00162"><sup>2</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>Tang</surname><given-names>Hai-Feng</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-00162"><sup>1</sup></xref><xref ref-type="corresp" rid="c1-marinedrugs-09-00162"><sup>*</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Yu-Shan</given-names></name><xref ref-type="aff" rid="af2-marinedrugs-09-00162"><sup>2</sup></xref><xref ref-type="corresp" rid="c1-marinedrugs-09-00162"><sup>*</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>Lin</surname><given-names>Hou-Wen</given-names></name><xref ref-type="aff" rid="af3-marinedrugs-09-00162"><sup>3</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname><given-names>Xiao-Li</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-00162"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>Ma</surname><given-names>Ning</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-00162"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>Yao</surname><given-names>Min-Na</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-09-00162"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Ping-Hu</given-names></name><xref ref-type="aff" rid="af4-marinedrugs-09-00162"><sup>4</sup></xref></contrib></contrib-group>
<aff id="af1-marinedrugs-09-00162">
<label>1</label> Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shannxi, China; E-Mail: <email>tianxangrong@163.com</email> (X.-R.T.)</aff>
<aff id="af2-marinedrugs-09-00162">
<label>2</label> School of Traditional Chinese Medicines, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China</aff>
<aff id="af3-marinedrugs-09-00162">
<label>3</label> Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200433, China; E-Mail: <email>franklin67@126.com</email> (H.-W.L.)</aff>
<aff id="af4-marinedrugs-09-00162">
<label>4</label> Jiangsu Center for Drug Screening &amp; National Drug Screening Laboratory, China Pharmaceutical University, Nanjing 210009, Jiangsu, China; E-Mail: <email>308694164@qq.com</email> (P.-H.Z.)</aff>
<author-notes>
<corresp id="c1-marinedrugs-09-00162">
<label>*</label>Authors to whom correspondence should be addressed; E-Mails: <email>tanghaifeng71@163.com</email> (H.-F.T); <email>liyushan8888@yahoo.com.cn</email> (Y.-S.L); Tel.: +86-29-84775471 (H.-F.T); Fax: +86-29-84775471 (H.-F.T).</corresp></author-notes>
<pub-date pub-type="collection">
<year>2011</year></pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>1</month>
<year>2011</year></pub-date>
<volume>9</volume>
<issue>2</issue>
<fpage>162</fpage>
<lpage>183</lpage>
<history>
<date date-type="received">
<day>18</day>
<month>12</month>
<year>2010</year></date>
<date date-type="rev-recd">
<day>13</day>
<month>1</month>
<year>2011</year></date>
<date date-type="accepted">
<day>24</day>
<month>1</month>
<year>2011</year></date></history>
<permissions>
<copyright-statement>© 2011 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
<copyright-year>2011</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p></license></permissions>
<abstract>
<p>Six new sterols (<bold>1</bold>–<bold>6</bold>), together with seven known sterols (<bold>7</bold>–<bold>13</bold>), were isolated from the CCl<sub>4</sub> extract of the marine bryozoan <italic>Cryptosula pallasiana</italic>, four (<bold>3</bold>–<bold>6</bold>) of which have already been reported as synthetic sterols. This is the first time that these compounds (<bold>3</bold>–<bold>6</bold>) are reported as natural sterols. The structures of the new compounds were determined on the basis of the extensive spectroscopic analysis, including two-dimensional (2D) NMR and HR-ESI-MS data. Compounds <bold>1</bold>–<bold>4</bold>, <bold>7</bold> and <bold>10</bold>–<bold>13</bold> were evaluated for their cytotoxicity against HL-60 human myeloid leukemia cell line, and all of the evaluated compounds exhibited moderate cytotoxicity to HL-60 cells with a range of IC<sub>50</sub> values from 14.73 to 22.11 μg/mL except for compounds <bold>12</bold> and <bold>13</bold>.</p></abstract>
<kwd-group>
<kwd>marine bryozoan</kwd>
<kwd><italic>Cryptosula pallasiana</italic></kwd>
<kwd>oxygenated sterols</kwd>
<kwd>cytotoxicity</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<label>1.</label>
<title>Introduction</title>
<p>Marine bryozoans are well known producers of bioactive secondary metabolites and important marine drug sources due to their remarkable antineoplastic activity [<xref ref-type="bibr" rid="b1-marinedrugs-09-00162">1</xref>]. Bryostatins isolated from the marine bryozoans <italic>Bugula neritina</italic> are a well known example [<xref ref-type="bibr" rid="b2-marinedrugs-09-00162">2</xref>]. Other bioactive secondary metabolities from marine bryozoans include alkaloids, sterols, as well as heteratom-containing compounds, which showed remarkable activities on tumor cell lines, such as murine lymphocytic leukemia P388, human myeloid leukemia HL-60, human leukemia U937, human hepatocellular liver carcinoma HepG2, <italic>etc</italic>. [<xref ref-type="bibr" rid="b3-marinedrugs-09-00162">3</xref>–<xref ref-type="bibr" rid="b6-marinedrugs-09-00162">6</xref>]. In our previous studies focused on <italic>B. neritina</italic>, a new antineoplastic macrolide, bryostatin 19, two ceramides and four cerebrosides, as well as a series of sterols were isolated from this bryozoan [<xref ref-type="bibr" rid="b5-marinedrugs-09-00162">5</xref>–<xref ref-type="bibr" rid="b8-marinedrugs-09-00162">8</xref>]. In the course of our ongoing investigations toward the isolation of biologically active secondary metabolites from marine bryozoans, <italic>Cryptosula pallasiana</italic> was investigated, another genus of marine bryozoans, collected from the coast of Huang Island in Qingdao City, Shandong Province of China. Herein, we report the isolation and structure identification of six new sterols (<bold>1</bold>–<bold>6</bold>) and seven known sterols (<bold>7</bold>–<bold>13</bold>), four (<bold>3</bold>–<bold>6</bold>) of which have already been reported as synthetic sterols [<xref ref-type="bibr" rid="b9-marinedrugs-09-00162">9</xref>–<xref ref-type="bibr" rid="b11-marinedrugs-09-00162">11</xref>]. This is the first time that these compounds (<bold>3</bold>–<bold>6</bold>) are reported as natural sterols. In addition, the cytotoxicity of the oxygenated sterols <bold>1</bold>–<bold>4</bold>, <bold>7</bold> and <bold>10</bold>–<bold>13</bold> against HL-60 human myeloid leukemia cell line is also described.</p></sec>
<sec sec-type="results|discussion">
<label>2.</label>
<title>Results and Discussion</title>
<p>The CCl<sub>4</sub> extract (12.9 g) of the marine bryozoan <italic>C. pallasiana</italic> was fractionated by Sephadex LH-20 chromatography to afford three major fractions (Frs. A–C). Fr. A (5.66 g) was further subjected to column chromatography (CC) over reversed-phase silica gel column (RP-18) and normal silica gel column, respectively, and then further purified by reverse semi-preparation HPLC to yield compounds <bold>1</bold>–<bold>13</bold> (<xref ref-type="fig" rid="f1-marinedrugs-09-00162">Figure 1</xref>).</p>
<p>Compound <bold>1</bold> was obtained as a white amorphous powder and was positive to Liebermann-Burchard test. The positive ion mode HR-ESI-MS spectrum showed a pseudomolecular ion peak at <italic>m/z</italic> 437.3398 [M + Na]<sup>+</sup> (C<sub>28</sub>H<sub>46</sub>O<sub>2</sub>Na, calculated for 437.3396), which, together with the molecular ion peak at <italic>m/z</italic> 414 [M]<sup>+</sup> in the positive ion mode EI-MS, enabled the determination of the molecular formula C<sub>28</sub>H<sub>46</sub>O<sub>2</sub>, with the help of NMR data (<xref ref-type="table" rid="t1-marinedrugs-09-00162">Table 1</xref>).</p>
<p>An extensive examination of <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra data, to draw assistance from the data of <sup>1</sup>H-<sup>1</sup>H COSY, HSQC and HMBC spectra, allowed the establishment of a sterol skeleton with a 5(6)-double bond (<italic>δ</italic><sub>C</sub> 140.9 and 121.8), which was consistent with the literature [<xref ref-type="bibr" rid="b12-marinedrugs-09-00162">12</xref>]. The <sup>1</sup>H NMR spectrum showed five methyl resonance signals at <italic>δ</italic><sub>H</sub> 0.69 (3H, s), 0.91 (3H, d, <italic>J</italic> = 6.6 Hz), 1.00 (3H, s), and 1.25 (6H, s), which were ascribed to the methyl groups 18, 21, 19 and 26/27, respectively. The resonances at <italic>δ</italic><sub>H</sub> 3.52 (1H, m) and 5.35 (1H, t, <italic>J</italic> = 2.9 Hz) assigned for H-3 and the olefinic proton H-6, respectively, were indicative for Δ<sup>5</sup> mon-hydroxylated steroidal nucleus, which was confirmed by HMBC correlations from H-6 to C-4 (<italic>δ</italic><sub>C</sub> 42.4), C-7 (<italic>δ</italic><sub>C</sub> 32.0), C-8 (<italic>δ</italic><sub>C</sub> 32.0) and C-10 (<italic>δ</italic><sub>C</sub> 36.6) (<xref ref-type="fig" rid="f2-marinedrugs-09-00162">Figure 2</xref>), as well as <sup>1</sup>H-<sup>1</sup>H COSY correlations from H-3 to H<sub>2</sub>-2 and H<sub>2</sub>-4. The partial structure of C-17 side chain in compound <bold>1</bold> was established based on EI-MS, 1D and 2D NMR data. The double bond of C-23 (<italic>δ</italic><sub>C</sub> 128.8) and C-24 (<italic>δ</italic><sub>C</sub> 136.8) was confirmed by the cross peaks of H-23 (<italic>δ</italic><sub>H</sub> 5.50, m) to C-22 (<italic>δ</italic><sub>C</sub> 39.3), C-24 and C-25 (<italic>δ</italic><sub>C</sub> 75.0); H-24 (<italic>δ</italic><sub>H</sub> 5.38, d, <italic>J</italic> = 15.8 Hz) to C-22 and C-23 in the HMBC spectrum, and was determined to be <italic>trans</italic>-disubstituted due to the large coupling constant (<italic>J</italic><sub>23,24</sub> = 15.8 Hz). The methoxy group (<italic>δ</italic><sub>H</sub> 3.15 (3H, s), <italic>δ</italic><sub>C</sub> 50.4) at C-25 position was confirmed by the HMBC spectrum data (<xref ref-type="fig" rid="f2-marinedrugs-09-00162">Figure 2</xref>) and fragment ion at <italic>m/z</italic> 382 [M <italic>−</italic> OCH<sub>3</sub> <italic>−</italic> H]<sup>+</sup> in the EI-MS spectrum of <bold>1</bold>. Based on the above analysis, the plane structure of <bold>1</bold> was determined (<xref ref-type="fig" rid="f1-marinedrugs-09-00162">Figure 1</xref>).</p>
<p>In the NOESY experiment, both H-3 and H-6 correlated with H-4<italic>α</italic> (<italic>δ</italic><sub>H</sub> 2.28, m), indicating the <italic>β</italic>-orientation of the hydroxyl group on C-3 (<xref ref-type="fig" rid="f2-marinedrugs-09-00162">Figure 2</xref>), which was confirmed by the chemical shift of C-3 (<italic>δ</italic><sub>C</sub> 71.9 &gt; 70.0) [<xref ref-type="bibr" rid="b13-marinedrugs-09-00162">13</xref>]. After mapping all of the signals for each moiety by careful inspection of the 1D and 2D NMR spectra, compound <bold>1</bold> was unambiguously assigned as (23<italic>E</italic>)-25-methoxy-cholesta-5,23-dien-3<italic>β</italic>-ol. Sterol <bold>1</bold>, not reported previously in the literature, is a new sterol with <italic>trans</italic>-double bonds between C-23 and C-24, together with a methoxy group at C-25 in the side chain.</p>
<p>Compound <bold>2</bold> was isolated as an isomer of <bold>1</bold>, due to the same formula of C<sub>28</sub>H<sub>46</sub>O<sub>2</sub> from EI-MS (<italic>m/z</italic> 414 [M]<sup>+</sup>) and HR-ESI-MS (<italic>m/z</italic> 437.3394 [M + Na]<sup>+</sup> (C<sub>28</sub>H<sub>46</sub>O<sub>2</sub>Na, calculated for 437.3396)), with the help of 1D NMR spectral data. Fragment at <italic>m/z</italic> 382 [M <italic>−</italic> OCH<sub>3</sub> <italic>−</italic> H]<sup>+</sup> due to loss of a methoxy group, as well as the two ion fragments at <italic>m/z</italic> 271 [M <italic>−</italic> C<sub>8</sub>H<sub>15</sub> <italic>−</italic> OCH<sub>3</sub> <italic>−</italic> H]<sup>+</sup> and 253 [M <italic>−</italic> C<sub>8</sub>H<sub>15</sub> <italic>−</italic> OCH<sub>3</sub> <italic>−</italic> H <italic>−</italic> H<sub>2</sub>O]<sup>+</sup>, suggested the presence of the mono-hydroxylated and mono-methoxylated steroid with a mono-unsaturated side chain. The presence of a strong peak in the EI-MS at <italic>m/z</italic> 111 confirmed the presence of the C<sub>8</sub>H<sub>15</sub> side chain. The partial structure of a Δ<sup>22</sup> mono-unsaturated side chain was established from the HMBC spectrum of <bold>2</bold> (<xref ref-type="fig" rid="f2-marinedrugs-09-00162">Figure 2</xref>), which showed correlations of H<sub>3</sub>-27/C-25, H<sub>3</sub>-26/C-25, H<sub>3</sub>-26/C-24, H-23/C-24, H-23/C-20, H-22/C-23, H-22/C-20, H<sub>3</sub>-21/C-17, H<sub>3</sub>-21/C-20 and H<sub>3</sub>-21/C-22. The position of the methoxy group was assigned as C-7 (<italic>δ</italic><sub>C</sub> 74.1) due to a strong broad singlet at <italic>δ</italic><sub>H</sub> 3.35 (3H, s) correlated to C-7 in the HMBC spectrum, and the partial structure of the steroidal nucleus was confirmed by the observation of the HMBC cross peaks from H<sub>2</sub>-4 to C-3, C-5 and C-6; H-6 to C-4, C-8 and C-10; H<sub>3</sub>-18 to C-13, C-14 and C-17, and H<sub>3</sub>-19 to C-1 and C-10 (<xref ref-type="fig" rid="f2-marinedrugs-09-00162">Figure 2</xref>). The configuration of the double bond between C-22 and C-23 was determined to be <italic>trans</italic>-disubstituted due to the large coupling constant (<italic>J</italic><sub>22,23</sub> = 15.2 Hz) between H-22 and H-23. The <italic>β</italic>-orientation of the hydroxyl group on C-3 was deduced also from the NOESY correlations of H-3/H-4<italic>α</italic> and H-4<italic>α</italic>/H-6, and the <italic>β</italic>-orientation of the methoxy group on C-7 was deduced by observation of correlations of H-7<italic>α</italic>/H-6 and H-7<italic>α</italic>/H-14 in the NOESY experiment (<xref ref-type="fig" rid="f2-marinedrugs-09-00162">Figure 2</xref>). Accordingly, compound <bold>2</bold> can be defined as (22<italic>E</italic>)-7<italic>β</italic>-methoxy-cholesta-5,22-dien-3<italic>β</italic>-ol.</p>
<p>Compound <bold>3</bold> was isolated as a white amorphous powder and was also positive to the Libermann-Burchard test. Its molecular formula was established as C<sub>28</sub>H<sub>48</sub>O<sub>2</sub> by observation of the molecular ion peak at <italic>m/z</italic> 439.3550 [M + Na]<sup>+</sup> (C<sub>28</sub>H<sub>48</sub>O<sub>2</sub>Na, calculated for 439.3552) in the HR-ESI-MS spectrum and ion peak at <italic>m/z</italic> 416 [M]<sup>+</sup> in the EI-MS spectrum. Comparison of the <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra of <bold>3</bold> with those of <bold>2</bold> revealed that they shared the same 3<italic>β</italic>-hydroxy, 7<italic>β</italic>-methoxy Δ<sup>5</sup>-steroid nucleus but differed in the side chain. Compound <bold>3</bold> was finally assigned as 7<italic>β</italic>-methoxy-cholest-5-en-3<italic>β</italic>-ol due to the missing <italic>trans</italic>-double bonds between C-22 and C-23 in the <sup>13</sup>C NMR spectrum by comparison with <bold>2</bold>. Compound <bold>3</bold> has been reported as a synthetic sterol with effective inhibition of cholesterol acyltransferase (ACAT) [<xref ref-type="bibr" rid="b9-marinedrugs-09-00162">9</xref>] and is reported here as a natural product for the first time.</p>
<p>Compound <bold>4</bold> was obtained as a white amorphous powder and was positive to Liebermann-Burchard test. The HR-ESI-MS spectrum showed the molecular ion peak at <italic>m/z</italic> 407.2928 [M + Na]<sup>+</sup> (C<sub>26</sub>H<sub>40</sub>O<sub>2</sub>Na, calculated for 407.2926) and EI-MS spectrum showed the molecular ion peak at <italic>m/z</italic> 384 [M]<sup>+</sup> corresponding to the molecular formula C<sub>26</sub>H<sub>40</sub>O<sub>2</sub>, with the help of NMR data. Compound <bold>4</bold> was assumed to have the same typical nucleus of 3<italic>β</italic>-hydroxy Δ<sup>5</sup>-steroid by comparing the 1D NMR data with those of <bold>1</bold>, but differed in the side chain. The protons of <italic>trans</italic>-olefinic bonds in the side chain appeared at <italic>δ</italic><sub>H</sub> 6.07 (1H, d, <italic>J</italic> = 15.5 Hz) and 6.78 (1H, m). The HSQC spectral data indicated that the proton H-24 (<italic>δ</italic><sub>H</sub> 6.07) was connected to the carbon at <italic>δ</italic><sub>C</sub> 132.8 (C-24) and H-23 (<italic>δ</italic><sub>H</sub> 6.78) was connected to the carbon at <italic>δ</italic><sub>C</sub> 147.6 (C-23), while the protons H<sub>2</sub>-22 (<italic>δ</italic><sub>H</sub> 2.34, 1.98) were connected to the carbon at <italic>δ</italic><sub>C</sub> 39.5 (C-22). The correlation of H-23 with H<sub>2</sub>-22 and H-24 in the <sup>1</sup>H-<sup>1</sup>H COSY spectrum indicated that the double bonds were in C-23 and C-24. This was also supported by the key cross-peaks H-24 with C-22 and H-23 with C-22 in the HMBC experiment. Similarly, the downfield singlet methyl protons at <italic>δ</italic><sub>H</sub> 2.25 (H<sub>3</sub>-26) exhibited HMBC correlations with C-25 (<italic>δ</italic><sub>C</sub> 198.7) and C-24, and upfield methyl proton signals at <italic>δ</italic><sub>H</sub> 0.95 (H<sub>3</sub>-21) with C-17 (<italic>δ</italic><sub>C</sub> 55.9), C-20 (<italic>δ</italic><sub>C</sub> 36.0) and C-22, suggesting the remnant connectivities of the side chain in compound <bold>4</bold>. Accordingly, <bold>4</bold> was finally assigned as (23<italic>E</italic>)-3<italic>β</italic>-hydroxy-27-norcholesta-5,23-dien-25-one, which had been obtained by synthesis [<xref ref-type="bibr" rid="b10-marinedrugs-09-00162">10</xref>], but was reported as a natural product for the first time.</p>
<p>Another two stereoisomeric sterols, <bold>5</bold> and <bold>6</bold>, were isolated as white amorphous powder, and were analyzed to share the same molecular formula of C<sub>27</sub>H<sub>44</sub>O<sub>2</sub> using EI-MS (<italic>m/z</italic> 400 [M]<sup>+</sup>) and HR-ESI-MS data. The <sup>1</sup>H NMR and <sup>13</sup>C NMR data of <bold>5</bold> and <bold>6</bold> agreed with those of cholesta-5,25-diene-3<italic>β</italic>,24<italic>ξ</italic>-diol from red alga <italic>Galaxaura marginata</italic> [<xref ref-type="bibr" rid="b14-marinedrugs-09-00162">14</xref>]. Although, the configuration at C-24 was hard to determine due to the small difference in the chemical shift of C-24 in the <sup>13</sup>C NMR spectrum between <italic>S</italic> and <italic>R</italic> epimers (<xref ref-type="table" rid="t2-marinedrugs-09-00162">Table 2</xref>), compound <bold>5</bold> was finally assigned as 24(<italic>R</italic>)-cholesta-5,25-diene-3<italic>β</italic>,24-diol due to no correlation between H-24 and H-20<italic>β</italic> in the NOESY experiment, whereas, the presence of H-24 correlated with H-20<italic>β</italic> in <bold>6</bold> confirmed the correct configuration of C-24 in <bold>5</bold>. Furthermore, the results were confirmed by the <sup>1</sup>H NMR data of <bold>5</bold> and <bold>6</bold>, consistent with the same synthetic sterols reported earlier [<xref ref-type="bibr" rid="b11-marinedrugs-09-00162">11</xref>]. Accordingly, <bold>6</bold> was assigned to be 24(<italic>S</italic>)-cholesta-5,25-diene-3<italic>β</italic>,24-diol. <bold>5</bold> and <bold>6</bold> as stereoisomeric sterols were isolated from a natural origin for the first time.</p>
<p>Comparing their MS and NMR data with those reported in the literature, the known sterols were identified as (23<italic>Z</italic>)-cholesta-5,23-diene-3<italic>β</italic>,25-diol (<bold>7</bold>) [<xref ref-type="bibr" rid="b15-marinedrugs-09-00162">15</xref>], cholest-5-ene-3<italic>β</italic>,7<italic>β</italic>-diol (<bold>8</bold>) [<xref ref-type="bibr" rid="b16-marinedrugs-09-00162">16</xref>], cholest-5-ene-3<italic>β</italic>,7<italic>α</italic>-diol (<bold>9</bold>) [<xref ref-type="bibr" rid="b16-marinedrugs-09-00162">16</xref>], (22<italic>E</italic>)-3<italic>β</italic>-hydroxy-24-norcholesta-5,22-dien-7-one (<bold>10</bold>) [<xref ref-type="bibr" rid="b16-marinedrugs-09-00162">16</xref>], (22<italic>E</italic>)-3<italic>β</italic>-hydroxycholesta-5,22-dien-7-one (<bold>11</bold>) [<xref ref-type="bibr" rid="b16-marinedrugs-09-00162">16</xref>], 3<italic>β</italic>-hydroxycholest-5-en-7-one (<bold>12</bold>) [<xref ref-type="bibr" rid="b16-marinedrugs-09-00162">16</xref>] and (4<italic>E</italic>,22<italic>E</italic>)-12<italic>β</italic>-hydroxy-24-norcholesta-1,4,22-trien-3-one (<bold>13</bold>) [<xref ref-type="bibr" rid="b17-marinedrugs-09-00162">17</xref>], respectively. The <italic>cis</italic>-double bonds between C-23 and C-24, together with an oxygenated hydroxyl group at C-25 in the side chain of <bold>7</bold> is scarce in natural sterols. Sterols <bold>8</bold>–<bold>12</bold> were previously isolated from two marine sponges <italic>Cliona copiosa</italic> [<xref ref-type="bibr" rid="b16-marinedrugs-09-00162">16</xref>] and <italic>Stelodoryx chlorophylla</italic> [<xref ref-type="bibr" rid="b18-marinedrugs-09-00162">18</xref>], and sterols <bold>8</bold>–<bold>9</bold> were also isolated from a soft coral <italic>Dendronephthya gigantean</italic> [<xref ref-type="bibr" rid="b19-marinedrugs-09-00162">19</xref>] and a marine bryozoan <italic>Biflustra grandicella</italic> [<xref ref-type="bibr" rid="b20-marinedrugs-09-00162">20</xref>]. Compound <bold>13</bold> was a highly functionalized C<sub>26</sub> steroid Δ<sup>1,4</sup>-dien-3-one with 12<italic>β</italic> oxygen function, which is a rare structural feature among sterols and has been isolated from soft coral <italic>Gersemia rubiformis</italic> [<xref ref-type="bibr" rid="b17-marinedrugs-09-00162">17</xref>]. However, all of the known sterols were isolated for the first time from this species.</p>
<p>Compounds <bold>1</bold>–<bold>4</bold>, <bold>7</bold> and <bold>10</bold>–<bold>13</bold> were evaluated for their cytotoxicity against HL-60 human myeloid leukemia cells <italic>in vitro</italic>, using a MTT assay method. The results of their cytotoxicity are shown in <xref ref-type="table" rid="t3-marinedrugs-09-00162">Table 3</xref>. Although <bold>12</bold> and <bold>13</bold> did not show any apparent cytotoxicity, sterols <bold>1</bold>–<bold>4</bold>, <bold>7</bold>, <bold>10</bold> and <bold>11</bold> displayed moderate cytotoxicity to HL-60 cells with IC<sub>50</sub> values of 17.91, 21.30, 22.11, 15.05, 18.28, 15.12 and 14.73 μg/mL, respectively. It appears that the cytotoxicity against HL-60 human myeloid leukemia cells of these sterols has a correlation with their structure.</p>
<p>The present chemical study of the marine bryozoan <italic>C. pallasiana</italic> resulted in the isolation and characterization of six new sterols (<bold>1</bold>–<bold>6</bold>) and seven known sterols (<bold>7</bold>–<bold>13</bold>), four (<bold>3</bold>–<bold>6</bold>) of which have already been reported as synthetic sterols [<xref ref-type="bibr" rid="b9-marinedrugs-09-00162">9</xref>–<xref ref-type="bibr" rid="b11-marinedrugs-09-00162">11</xref>]. This is the first time that they (<bold>3</bold>–<bold>6</bold>) are reported as natural sterols. The structures of these new compounds are notable for the following viewpoints of natural product chemistry. Sterol <bold>1</bold>, not reported previously in the literature, is characterized by an oxygenated methoxy group at C-25 in the side chain. In the nucleus of <bold>2</bold> and <bold>3</bold>, the 7<italic>β</italic> methoxy group is a rare feature and first encountered among natural sterols. Compound <bold>4</bold> is specific in carbonylation at C-25 accompanied by a loss of a methyl group in the side chain. Sterols <bold>5</bold> and <bold>6</bold> are stereoisomeric with the C-24 with hydroxyl group in the side chain, which are reported as a natural source for the first time.</p></sec>
<sec>
<label>3.</label>
<title>Experimental Section</title>
<sec sec-type="methods">
<label>3.1.</label>
<title>General Experimental Procedures</title>
<p>Optical rotations were measured on a Perkin-Elmer 343 polarimeter. 1D and 2D NMR spectra experiments were measured in CDCl<sub>3</sub> on a Bruker AVANCE-500 spectrometer, with TMS as an internal standard. Chemical shifts (<italic>δ</italic>) were expressed in ppm and coupling constants in Hz. EI-MS spectra were obtained on a MAT212 mass spectrometer; ESI-MS and HR-ESI-MS spectra were taken on a Micromass Quattro mass spectrometer. Separation and purification were performed by CC on silica gel H (10–40 μm, Qingdao Marine Chemical Inc., Qingdao, China), Sephadex LH-20 (Pharmacia Inc., New Jersey, USA), reversed-phase Si gel (Lichroprep RP-18, 40–63 μm, Merck Inc., Darmstadt, Germany). HPLC was carried out on a Dionex P680 liquid chromatograph equipped with a UV 170 UV/Vis detector at 206 nm using a YMC-Pack R &amp; D ODS-A column (250 × 20 mm i.d., 5 μm, YMC, Kyoto, Japan) for semi-preparation and a Thermo ODS-2 column (250 × 4.6 mm i.d., 5 μm, Thermo Hypersi-Keystone Inc., Bellefonte, U.S.A.) for analysis. TLC detection was achieved by spraying the silica gel plates (Qingdao Marine Chemical Inc., Qingdao, China) with 20% H<sub>2</sub>SO<sub>4</sub> followed by heating.</p></sec>
<sec>
<label>3.2.</label>
<title>Animal Material</title>
<p>The samples of marine bryozoan <italic>Cryptosula pallasiana</italic> were collected in March 2009 from Huang Island, Qingdao City, Shandong Province of China, and were identified by one of the authors (Prof. H.-W. Lin). A voucher specimen (No: QD-0903-1) was deposited in Marine Laboratory, Changzheng Hospital, Second Military Medical University.</p></sec>
<sec>
<label>3.3.</label>
<title>Extraction and Isolation</title>
<p>Fresh samples of <italic>Cryptosula pallasiana</italic> (about 20 kg) were extracted with 95% EtOH at ambient temperature. The concentrated aqueous solution was extracted with EtOAc. Then, the extract was partitioned between 90% aqueous MeOH and petroleum ether. The MeOH solution was adjusted to 80% aqueous MeOH and extracted with CCl<sub>4</sub>. The CCl<sub>4</sub> fraction (12.9 g) was subjected to column chromatography (CC) on Sephadex LH-20 with CHCl<sub>3</sub>/MeOH (1:1) as eluting solvent to afford three fractions (Frs. A–C) based on TLC analysis (developed by petroleum ether/EtOH, 5:1). Fr. A (5.66 g) was subjected to CC on reversed-phase silica gel column eluting with MeOH/H<sub>2</sub>O (80:20 to 100:0) gradient to give two major fractions A<sub>1</sub> (2.44 g) and A<sub>2</sub> (3.18 g). Fr. A<sub>2</sub> was submitted to CC over silica gel eluting with petroleum ether/EtOAc (15:1, 10:1, 5:1, 1:1) gradient to give 12 major fractions (Frs. A<sub>2</sub>-1–A<sub>2</sub>-12). Fr. A<sub>2</sub>-7 (238.9 mg) was eluted with CHCl<sub>3</sub>/MeOH (1:1) on Sephadex LH-20 and then further purified by semi-preparative HPLC to afford <bold>1</bold> (6.0 mg, <italic>t</italic><sub>R</sub> = 97.7 min), <bold>5</bold> (12.0 mg, <italic>t</italic><sub>R</sub> = 34.0 min), <bold>6</bold> (11.2 mg, <italic>t</italic><sub>R</sub> = 35.6 min) and <bold>7</bold> (11.4 mg, <italic>t</italic><sub>R</sub> = 38.4 min), using MeOH/H<sub>2</sub>O (87:13) as the mobile phase at a flow rate of 8.0 mL/min. Fr. A<sub>2</sub>-6 was purified by semi-preparative HPLC (MeOH/H<sub>2</sub>O 90:10, flow rate of 8.0 mL/min) to yield <bold>2</bold> (3.5 mg, <italic>t</italic><sub>R</sub> = 40.7 min), <bold>3</bold> (10.5 mg, <italic>t</italic><sub>R</sub> = 50.5 min) and <bold>4</bold> (2.0 mg, <italic>t</italic><sub>R</sub> = 16.8 min). Fr. A<sub>2</sub>-9 (577.0 mg) was firstly purified by semi-preparative HPLC (MeOH/H<sub>2</sub>O 90:10, flow rate of 8.0 mL/min) to give 12 fractions (Frs. A<sub>2</sub>-9-1–A<sub>2</sub>-9-12), and then the Fr. A<sub>2</sub>-9-12 (47.4 mg) was further purified by analytic HPLC to afford <bold>8</bold> (14.8 mg, <italic>t</italic><sub>R</sub> = 32.1 min) and <bold>9</bold> (18.2 mg, <italic>t</italic><sub>R</sub> = 35.4 min), using MeOH/H<sub>2</sub>O (87:13) as the mobile phase at a flow rate of 1.0 mL/min. Fr. A<sub>2</sub>-8 (147.5 mg) was eluted with CHCl<sub>3</sub>/MeOH (1:1) on Sephadex LH-20 and then further purified by semi-preparative HPLC to give <bold>10</bold> (3.4 mg, <italic>t</italic><sub>R</sub> = 71.8 min), <bold>11</bold> (4.1 mg, <italic>t</italic><sub>R</sub> = 98.3 min) and <bold>12</bold> (8.9 mg, <italic>t</italic><sub>R</sub> = 130.5 min), <bold>13</bold> (4.0 mg, <italic>t</italic><sub>R</sub> = 36.5 min), using MeOH/H<sub>2</sub>O (90:10) as the mobile phase at a flow rate of 8.0 mL/min.</p>
<sec>
<label>3.3.1.</label>
<title>Liebermann-Burchard Test</title>
<p>Each sample (1–2 mg) was dissolved in a mixture of 2 mL CHCl<sub>3</sub> and anhydrous acetic acid (1:1), then a few drops of concentrated sulfuric acid was added and mixed cautiously. The appearance of a green color indicated the presence of sterol.</p></sec>
<sec>
<label>3.3.2.</label>
<title>(23<italic>E</italic>)-25-Methoxy-cholesta-5,23-dien-3<italic>β</italic>-ol (<bold>1</bold>)</title>
<p>White amorphous powder; 
<inline-formula>
<mml:math>
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mo>α</mml:mo>
<mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow>
<mml:mtext>D</mml:mtext>
<mml:mrow>
<mml:mn>22</mml:mn></mml:mrow></mml:msubsup>
<mml:mo>−</mml:mo>
<mml:mn>40.7</mml:mn>
<mml:mo>°</mml:mo>
<mml:mi> </mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>c</mml:mi>
<mml:mi> </mml:mi>
<mml:mn>0.05</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi> </mml:mi>
<mml:msub>
<mml:mtext>CHCl</mml:mtext>
<mml:mn>3</mml:mn></mml:msub>
<mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>; <sup>1</sup>H NMR and <sup>13</sup>C NMR data, see <xref ref-type="table" rid="t1-marinedrugs-09-00162">Table 1</xref>; EI-MS <italic>m/z</italic>: 414 [M]<sup>+</sup> (16), 399 [M − CH<sub>3</sub>]<sup>+</sup> (100), 382 [M − OCH<sub>3</sub> − H]<sup>+</sup> (26), 367 (18), 349 (11), 301 [M − C<sub>6</sub>H<sub>10</sub>OCH<sub>3</sub>]<sup>+</sup> (25), 300 (30), 283 [M − C<sub>6</sub>H<sub>10</sub>OCH<sub>3</sub> − H<sub>2</sub>O]<sup>+</sup> (37), 271 (46), 241 (12), 227 (10), 215 (24), 183 (19), 159 (27), 133 (31), 113 [C<sub>6</sub>H<sub>10</sub>OCH<sub>3</sub>]<sup>+</sup> (28), 99 (47), 85 (61), 55 (42); HR-ESI-MS (positive) <italic>m/z</italic>: 437.3398 [M + Na]<sup>+</sup> (C<sub>28</sub>H<sub>46</sub>O<sub>2</sub>Na, calcd. for 437.3396).</p></sec>
<sec>
<label>3.3.3.</label>
<title>(22<italic>E</italic>)-7<italic>β</italic>-Methoxy-cholesta-5,22-dien-3<italic>β</italic>-ol (<bold>2</bold>)</title>
<p>White amorphous powder; 
<inline-formula>
<mml:math>
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mo>α</mml:mo>
<mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow>
<mml:mtext>D</mml:mtext>
<mml:mrow>
<mml:mn>22</mml:mn></mml:mrow></mml:msubsup>
<mml:mo>−</mml:mo>
<mml:mn>67.5</mml:mn>
<mml:mo>°</mml:mo>
<mml:mi> </mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>c</mml:mi>
<mml:mi> </mml:mi>
<mml:mn>0.05</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi> </mml:mi>
<mml:msub>
<mml:mtext>CHCl</mml:mtext>
<mml:mn>3</mml:mn></mml:msub>
<mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>; <sup>1</sup>H NMR and <sup>13</sup>C NMR data, see <xref ref-type="table" rid="t1-marinedrugs-09-00162">Table 1</xref>; EI-MS <italic>m/z</italic>: 414 [M]<sup>+</sup> (38), 396 [M − H<sub>2</sub>O]<sup>+</sup> (42), 382 [M − OCH<sub>3</sub> − H]<sup>+</sup> (100), 367 (8), 349 (12), 303 [M − C<sub>8</sub>H<sub>15</sub>]<sup>+</sup> (10), 298 (15), 271 [M − C<sub>8</sub>H<sub>15</sub> − OCH<sub>3</sub> − H]<sup>+</sup> (22), 253 (21), 211 (13), 197 (9), 175 (14), 159 (17), 145 (19), 135 (17), 119 (16), 111 [C<sub>8</sub>H<sub>15</sub>]<sup>+</sup> (22), 69 (30), 55 (37); HR-ESI-MS (positive) <italic>m/z</italic>: 437.3394 [M + Na]<sup>+</sup> (C<sub>28</sub>H<sub>46</sub>O<sub>2</sub>Na, calcd. for 437.3396).</p></sec>
<sec>
<label>3.3.4.</label>
<title>7<italic>β</italic>-Methoxy-cholest-5-en-3<italic>β</italic>-ol (<bold>3</bold>)</title>
<p>White amorphous powder; 
<inline-formula>
<mml:math>
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mo>α</mml:mo>
<mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow>
<mml:mtext>D</mml:mtext>
<mml:mrow>
<mml:mn>22</mml:mn></mml:mrow></mml:msubsup>
<mml:mo>−</mml:mo>
<mml:mn>72.4</mml:mn>
<mml:mo>°</mml:mo>
<mml:mi> </mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>c</mml:mi>
<mml:mi> </mml:mi>
<mml:mn>0.10</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi> </mml:mi>
<mml:msub>
<mml:mtext>CHCl</mml:mtext>
<mml:mn>3</mml:mn></mml:msub>
<mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) <italic>δ</italic>: 0.66 (3H, s, H<sub>3</sub>-18), 0.86 (3H, d, <italic>J</italic> = 2.3 Hz, H<sub>3</sub>-27), 0.87 (3H, d, <italic>J</italic> = 2.3 Hz, H<sub>3</sub>-26), 0.91 (3H, d, <italic>J</italic> = 6.5 Hz, H<sub>3</sub>-21), 0.98 (3H, s, H<sub>3</sub>-19), 2.34 (1H, m, H<italic><sub>α</sub></italic>-4), 2.29 (1H, m, H<italic><sub>β</sub></italic>-4), 3.29 (1H, t, <italic>J</italic> = 3.3 Hz, H-7), 3.36 (3H, s, H<sub>3</sub>-7−OCH<sub>3</sub>), 3.62 (1H, m, H-3), 5.73 (1H, dd, <italic>J</italic> = 4.9, 1.6 Hz, H-6); <sup>13</sup>C NMR data, see <xref ref-type="table" rid="t2-marinedrugs-09-00162">Table 2</xref>; EI-MS <italic>m/z</italic>: 416 [M]<sup>+</sup> (26), 398 [M − H<sub>2</sub>O]<sup>+</sup> (37), 384 [M − OCH<sub>3</sub> − H]<sup>+</sup> (100), 369 (11), 351 (12), 271 [M − C<sub>8</sub>H<sub>17</sub> − OCH<sub>3</sub> − H]<sup>+</sup> (7), 253 (5), 213 (6), 211 (7), 185 (5), 175 (9),159 (12), 145 (12), 119 (12), 95 (15), 81 (14), 69 (11), 55 (15); HR-ESI-MS (positive) <italic>m/z</italic>: 439.3550 [M + Na]<sup>+</sup> (C<sub>28</sub>H<sub>48</sub>O<sub>2</sub>Na, calcd. 439.3552).</p></sec>
<sec>
<label>3.3.5.</label>
<title>(23<italic>E</italic>)-3<italic>β</italic>-Hydroxy-27-norcholesta-5,23-dien-25-one (<bold>4</bold>)</title>
<p>White amorphous powder; 
<inline-formula>
<mml:math>
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mo>α</mml:mo>
<mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow>
<mml:mtext>D</mml:mtext>
<mml:mrow>
<mml:mn>22</mml:mn></mml:mrow></mml:msubsup>
<mml:mo>−</mml:mo>
<mml:mn>46.7</mml:mn>
<mml:mo>°</mml:mo>
<mml:mi> </mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>c</mml:mi>
<mml:mi> </mml:mi>
<mml:mn>0.02</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi> </mml:mi>
<mml:msub>
<mml:mtext>CHCl</mml:mtext>
<mml:mn>3</mml:mn></mml:msub>
<mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) <italic>δ</italic>: 0.70 (3H, s, H<sub>3</sub>-18), 0.95 (3H, d, <italic>J</italic> = 6.6 Hz, H<sub>3</sub>-21), 1.01 (3H, s, H<sub>3</sub>-19), 2.25 (3H, s, H<sub>3</sub>-26), 3.52 (1H, m, H-3), 5.35 (1H, t, <italic>J</italic> = 2.8 Hz, H-6), 6.07 (1H, d, <italic>J</italic> = 15.5 Hz, H-24), 6.78 (1H, m, H-23); <sup>13</sup>C NMR data, see <xref ref-type="table" rid="t2-marinedrugs-09-00162">Table 2</xref>; EI-MS <italic>m/z</italic>: 384 [M]<sup>+</sup> (100), 366 [M − H<sub>2</sub>O]<sup>+</sup> (66), 351 [M − CH<sub>3</sub> − H<sub>2</sub>O]<sup>+</sup> (40), 324 (9), 299 (29), 283 (32), 273 [M − Side Chain]<sup>+</sup> (41), 255 [M − H<sub>2</sub>O − Side Chain]<sup>+</sup> (23), 213 (45), 199 (19), 189 (29), 173 (24), 159 (48), 145 (54), 133 (44), 119 (46), 107 (62), 95 (52), 81 (54), 67 (38); HR-ESI-MS (positive) <italic>m/z</italic>: 407.2928 [M + Na]<sup>+</sup> (C<sub>26</sub>H<sub>40</sub>O<sub>2</sub>Na, calcd. for 407.2926)</p></sec>
<sec>
<label>3.3.6.</label>
<title>24(<italic>R</italic>)-Cholesta-5,25-diene-3<italic>β</italic>,24-diol (<bold>5</bold>)</title>
<p>White amorphous powder; 
<inline-formula>
<mml:math>
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mo>α</mml:mo>
<mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow>
<mml:mtext>D</mml:mtext>
<mml:mrow>
<mml:mn>22</mml:mn></mml:mrow></mml:msubsup>
<mml:mo>−</mml:mo>
<mml:mn>19.4</mml:mn>
<mml:mo>°</mml:mo>
<mml:mi> </mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>c</mml:mi>
<mml:mi> </mml:mi>
<mml:mn>0.10</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi> </mml:mi>
<mml:msub>
<mml:mtext>CHCl</mml:mtext>
<mml:mn>3</mml:mn></mml:msub>
<mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) <italic>δ</italic>: 0.68 (3H, s, H<sub>3</sub>-18), 0.93 (3H, d, <italic>J</italic> = 6.6 Hz, H<sub>3</sub>-21), 1.00 (3H, s, H<sub>3</sub>-19), 1.72 (3H, s, H<sub>3</sub>-27), 3.52 (1H, m, H-3), 4.00 (1H, t, <italic>J</italic> = 6.6 Hz, H-24), 4.83 (1H, t, <italic>J</italic> = 1.4 Hz, H<sub>a</sub>-26), 4.92 (1H, s, H<sub>b</sub>-26), 5.35 (1H, d, <italic>J</italic> = 5.2 Hz, H-6); <sup>13</sup>C NMR data, see <xref ref-type="table" rid="t2-marinedrugs-09-00162">Table 2</xref>; EI-MS <italic>m/z</italic>: 400 [M]<sup>+</sup> (41), 382 [M − H<sub>2</sub>O]<sup>+</sup> (56), 367 [M − CH<sub>3</sub> − H<sub>2</sub>O]<sup>+</sup> (33), 349 (25), 340 (10), 328 (13), 315 (22), 300 [M − C<sub>6</sub>H<sub>10</sub> − H<sub>2</sub>O]<sup>+</sup> (27), 271 [M − C<sub>8</sub>H<sub>15</sub> − H<sub>2</sub>O]<sup>+</sup> (100), 255 (36), 243 (17), 229 (31), 213 (46), 199 (23), 187 (26), 173 (30), 161 (49), 145 (52), 133 (46), 119 (46), 107 (58), 95 (56), 81 (60), 71 (65), 55 (63); HR-ESI-MS (positive) <italic>m/z</italic>: 423.3241 [M + Na]<sup>+</sup> (C<sub>27</sub>H<sub>44</sub>O<sub>2</sub>Na, calcd. for 423.3239).</p></sec>
<sec>
<label>3.3.7.</label>
<title>24(<italic>S</italic>)-Cholesta-5,25-diene-3<italic>β</italic>,24-diol (<bold>6</bold>)</title>
<p>White amorphous powder, 
<inline-formula>
<mml:math>
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mo>α</mml:mo>
<mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow>
<mml:mtext>D</mml:mtext>
<mml:mrow>
<mml:mn>22</mml:mn></mml:mrow></mml:msubsup>
<mml:mo>−</mml:mo>
<mml:mn>27.9</mml:mn>
<mml:mo>°</mml:mo>
<mml:mi> </mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>c</mml:mi>
<mml:mi> </mml:mi>
<mml:mn>0.10</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi> </mml:mi>
<mml:msub>
<mml:mtext>CHCl</mml:mtext>
<mml:mn>3</mml:mn></mml:msub>
<mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) <italic>δ</italic>: 0.68 (3H, s, H<sub>3</sub>-18), 0.93 (3H, d, <italic>J</italic> = 6.6 Hz, H<sub>3</sub>-21), 1.00 (3H, s, H<sub>3</sub>-19), 1.72 (3H, s, H<sub>3</sub>-27), 3.52 (1H, m, H-3), 4.00 (1H, t, <italic>J</italic> = 6.4 Hz, H-24), 4.83 (1H, t, <italic>J</italic> = 1.4 Hz, H<sub>a</sub>-26), 4.93 (1H, s, H<sub>b</sub>-26), 5.35 (1H, d, <italic>J</italic> = 5.3 Hz, H-6); <sup>13</sup>C NMR data, see <xref ref-type="table" rid="t2-marinedrugs-09-00162">Table 2</xref>; EI-MS <italic>m/z</italic>: 400 [M]<sup>+</sup> (41), other ion fragments identical with <bold>5</bold>; HR-ESI-MS (positive) <italic>m/z</italic>: 423.3237 [M + Na]<sup>+</sup> (C<sub>27</sub>H<sub>44</sub>O<sub>2</sub>Na, calcd. for 423.3239).</p></sec></sec>
<sec>
<label>3.4.</label>
<title>MTT Cytotoxicity Assays</title>
<p>The cytotoxicity of compounds <bold>1</bold>–<bold>4</bold>, <bold>7</bold> and <bold>10</bold>–<bold>13</bold> were evaluated against HL-60 cancer cell line by microculture tetrazolium (MTT) assay [<xref ref-type="bibr" rid="b21-marinedrugs-09-00162">21</xref>]. The cells were obtained from American Type Culture Collection (ATCC), and maintained in RPMI 1640 medium (Gibco, Invitrogen Co., USA) containing 10% fetal bovine serum (Gibco, Invitrogen Co., USA) supplemented with 100 U/mL penicillin, and 100 U/mL streptomycin. The leukemia cells were washed and re-suspended in the above medium to 1 × 10<sup>5</sup> cells/mL. 2 mL of this cell suspension was placed into 96-well microculture plates and allowed to adhere in 5% CO<sub>2</sub>/air for 24 h at 37 °C before drug addition. 20 μL of DMSO solution containing the sample was added to give the various concentrations in triplicate for 72 h, with adriamycin (Sigma) as positive control. After the incubation, 20 μL of MTT solution (5 mg/mL) was added to each well, and the incubation continued for 4 h at 37 °C. Then, 150 μL of DMSO solution was added to each well, and the formazan crystals in each well were dissolved by stirring with a pipette. The optical density (OD) was read on a plate reader on an ELISA reader (MK3, USA) at a wavelength of 570 nm. Each assay was done in triplicate, and inhibition was expressed as IC<sub>50</sub> value, which stands for inhibition of cell growth by 50%.</p></sec></sec>
<sec sec-type="supplementary-material">
<title>Supporting Information</title>
<list list-type="simple">
<list-item>
<p>S1: HR-ESI-MS of compound <bold>1</bold></p></list-item>
<list-item>
<p>S2: EI-MS of compound <bold>1</bold></p></list-item>
<list-item>
<p>S3: <sup>1</sup>H NMR spectrum (CDCl<sub>3</sub>, 500 MHz) of compound <bold>1</bold></p></list-item>
<list-item>
<p>S4: <sup>13</sup>C NMR spectrum (CDCl<sub>3</sub>, 125 MHz) of compound <bold>1</bold></p></list-item>
<list-item>
<p>S5: DEPT spectrum of compound <bold>1</bold></p></list-item>
<list-item>
<p>S6: HSQC spectrum of compound <bold>1</bold></p></list-item>
<list-item>
<p>S7: COSY spectrum of compound <bold>1</bold></p></list-item>
<list-item>
<p>S8: HMBC spectrum of compound <bold>1</bold></p></list-item>
<list-item>
<p>S9: TOCSY spectrum of compound <bold>1</bold></p></list-item>
<list-item>
<p>S10: NOESY spectrum of compound <bold>1</bold></p></list-item>
<list-item>
<p>S11: HR-ESI-MS of compound <bold>2</bold></p></list-item>
<list-item>
<p>S12: EI-MS of compound <bold>2</bold></p></list-item>
<list-item>
<p>S13: <sup>1</sup>H NMR spectrum (CDCl<sub>3</sub>, 500 MHz) of compound <bold>2</bold></p></list-item>
<list-item>
<p>S14: <sup>13</sup>C NMR spectrum (CDCl<sub>3</sub>, 125 MHz) of compound <bold>2</bold></p></list-item>
<list-item>
<p>S15: DEPT spectrum of compound <bold>2</bold></p></list-item>
<list-item>
<p>S16: HSQC spectrum of compound <bold>2</bold></p></list-item>
<list-item>
<p>S17: HMBC spectrum of compound <bold>2</bold></p></list-item>
<list-item>
<p>S18: COSY spectrum of compound <bold>2</bold></p></list-item>
<list-item>
<p>S19: TOCSY spectrum of compound <bold>2</bold></p></list-item>
<list-item>
<p>S20: NOESY spectrum of compound <bold>2</bold></p></list-item></list>
<supplementary-material id="s1-marinedrugs-09-00162" content-type="local-data">
<label><bold>S1.</bold> HR-ESI-MS of compound <bold>1.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s1.tif"/></supplementary-material>
<supplementary-material id="s2-marinedrugs-09-00162" content-type="local-data">
<label><bold>S2.</bold> EI-MS of compound <bold>1.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s2.tif"/></supplementary-material>
<supplementary-material id="s3-marinedrugs-09-00162" content-type="local-data">
<label><bold>S3.</bold> <sup>1</sup>H NMR spectrum of compound <bold>1.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s3.tif"/></supplementary-material>
<supplementary-material id="s4-marinedrugs-09-00162" content-type="local-data">
<label><bold>S4.</bold> <sup>13</sup>C NMR spectrum of compound <bold>1.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s4.tif"/></supplementary-material>
<supplementary-material id="s5-marinedrugs-09-00162" content-type="local-data">
<label><bold>S5.</bold> DEPT spectrum of compound <bold>1.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s5.tif"/></supplementary-material>
<supplementary-material id="s6-marinedrugs-09-00162" content-type="local-data">
<label><bold>S6.</bold> HSQC spectrum of compound <bold>1.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s6.tif"/></supplementary-material>
<supplementary-material id="s7-marinedrugs-09-00162" content-type="local-data">
<label><bold>S7.</bold> HMBC spectrum of compound <bold>1.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s7.tif"/></supplementary-material>
<supplementary-material id="s8-marinedrugs-09-00162" content-type="local-data">
<label><bold>S8.</bold> COSY spectrum of compound <bold>1.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s8.tif"/></supplementary-material>
<supplementary-material id="s9-marinedrugs-09-00162" content-type="local-data">
<label><bold>S9.</bold> TOCSY spectrum of compound <bold>1.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s9.tif"/></supplementary-material>
<supplementary-material id="s10-marinedrugs-09-00162" content-type="local-data">
<label><bold>S10.</bold> NOESY spectrum of compound <bold>1.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s10.tif"/></supplementary-material>
<supplementary-material id="s11-marinedrugs-09-00162" content-type="local-data">
<label><bold>S11.</bold> HR-ESI-MS spectrum of compound <bold>2.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s11.tif"/></supplementary-material>
<supplementary-material id="s12-marinedrugs-09-00162" content-type="local-data">
<label><bold>S12.</bold> EI-MS of compound <bold>2.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s12.tif"/></supplementary-material>
<supplementary-material id="s13-marinedrugs-09-00162" content-type="local-data">
<label><bold>S13.</bold> <sup>1</sup>H NMR spectrum of compound <bold>2.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s13.tif"/></supplementary-material>
<supplementary-material id="s14-marinedrugs-09-00162" content-type="local-data">
<label><bold>S14.</bold> <sup>13</sup>C NMR spectrum of compound <bold>2.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s14.tif"/></supplementary-material>
<supplementary-material id="s15-marinedrugs-09-00162" content-type="local-data">
<label><bold>S15.</bold> DEPT spectrum of compound <bold>2.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s15.tif"/></supplementary-material>
<supplementary-material id="s16-marinedrugs-09-00162" content-type="local-data">
<label><bold>S16.</bold> HSQC spectrum of compound <bold>2.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s16.tif"/></supplementary-material>
<supplementary-material id="s17-marinedrugs-09-00162" content-type="local-data">
<label><bold>S17.</bold> HMBC spectrum of compound <bold>2.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s17.tif"/></supplementary-material>
<supplementary-material id="s18-marinedrugs-09-00162" content-type="local-data">
<label><bold>S18.</bold> COSY spectrum of compound <bold>2.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s18.tif"/></supplementary-material>
<supplementary-material id="s19-marinedrugs-09-00162" content-type="local-data">
<label><bold>S19.</bold> TOCSY spectrum of compound <bold>2.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s19.tif"/></supplementary-material>
<supplementary-material id="s20-marinedrugs-09-00162" content-type="local-data">
<label><bold>S20.</bold> NOESY spectrum of compound <bold>2.</bold></label>
<media mimetype="image" mime-subtype="tif" xlink:href="marinedrugs-09-00162s20.tif"/></supplementary-material></sec></body>
<back>
<ack>
<p>This work was financially supported by National High-Tech Research and Development Project (863 Project, 2007AA09Z401). The authors are grateful to Hui-Min Wang, Mass Measurement Center, Shanghai Institute of Pharmaceutical Industry, for the MS measurements, and Min-Chang Wang, Nuclear Magnetic Resonance Center, Xi’an Modern Chemistry Research Institute, for the NMR measurements.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-marinedrugs-09-00162"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>DJ</given-names></name></person-group><article-title>Marine natural products</article-title><source>Nat Prod Rep</source><year>1998</year><volume>15</volume><fpage>113</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1039/a815113y</pub-id><pub-id pub-id-type="pmid">9586223</pub-id></citation></ref>
<ref id="b2-marinedrugs-09-00162"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>GR</given-names></name><name><surname>Herald</surname><given-names>CL</given-names></name><name><surname>Doubek</surname><given-names>DL</given-names></name><name><surname>Herald</surname><given-names>DL</given-names></name><name><surname>Arnold</surname><given-names>E</given-names></name><name><surname>Clardy</surname><given-names>J</given-names></name></person-group><article-title>Isolation and structure of bryostatin 1</article-title><source>J Am Chem Soc</source><year>1982</year><volume>104</volume><fpage>6846</fpage><lpage>6848</lpage><pub-id pub-id-type="doi">10.1021/ja00388a092</pub-id></citation></ref>
<ref id="b3-marinedrugs-09-00162"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>HP</given-names></name><name><surname>Kamano</surname><given-names>Y</given-names></name><name><surname>Ichihara</surname><given-names>Y</given-names></name><name><surname>Kizu</surname><given-names>H</given-names></name><name><surname>Komiyama</surname><given-names>K</given-names></name><name><surname>Itokawa</surname><given-names>H</given-names></name><name><surname>Pettit</surname><given-names>GR</given-names></name></person-group><article-title>Isolation and structure of convolutamydines B-D from marine broyzoan <italic>Amathia convoluta</italic></article-title><source>Tetrahedron</source><year>1995</year><volume>51</volume><fpage>5523</fpage><lpage>5528</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(95)00241-Y</pub-id></citation></ref>
<ref id="b4-marinedrugs-09-00162"><label>4.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Blackman</surname><given-names>AJ</given-names></name><name><surname>Walls</surname><given-names>JT</given-names></name></person-group><article-title>Bryozoan secondary metabolites and their chemical ecology</article-title><source>Studies in Natural Products Chemistry</source><person-group person-group-type="editor"><name><surname>Atta-ur-Rahman</surname></name></person-group><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>1995</year><fpage>73</fpage><lpage>112</lpage></citation></ref>
<ref id="b5-marinedrugs-09-00162"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>HW</given-names></name><name><surname>Yi</surname><given-names>YH</given-names></name><name><surname>Li</surname><given-names>WL</given-names></name><name><surname>Yao</surname><given-names>XS</given-names></name><name><surname>Wu</surname><given-names>HM</given-names></name></person-group><article-title>Bryostatin 19: A new antineoplastic component from <italic>Bugula neritina</italic> in the South China Sea</article-title><source>J Chin Mar Drugs</source><year>1998</year><volume>65</volume><fpage>1</fpage><lpage>3</lpage></citation></ref>
<ref id="b6-marinedrugs-09-00162"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>H-J</given-names></name><name><surname>Chen</surname><given-names>JT</given-names></name><name><surname>Tang</surname><given-names>HF</given-names></name><name><surname>Piao</surname><given-names>SJ</given-names></name><name><surname>Chen</surname><given-names>WS</given-names></name><name><surname>Lin</surname><given-names>HW</given-names></name></person-group><article-title>New cytotoxic oxygenated sterols from marine bryozoan <italic>Bugula neritina</italic></article-title><source>Nat Prod Res</source><year>2010</year><volume>2</volume><fpage>1</fpage><lpage>7</lpage></citation></ref>
<ref id="b7-marinedrugs-09-00162"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>XR</given-names></name><name><surname>Tang</surname><given-names>HF</given-names></name><name><surname>Li</surname><given-names>YS</given-names></name><name><surname>Lin</surname><given-names>HW</given-names></name><name><surname>Ma</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Yao</surname><given-names>MN</given-names></name></person-group><article-title>Ceramides and cerebrosides from the marine bryozoan <italic>Bugula neritina</italic> inbating South China Sea</article-title><source>J Asian Nat Prod Res</source><year>2009</year><volume>11</volume><fpage>1005</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1080/10286020903207050</pub-id><pub-id pub-id-type="pmid">20183269</pub-id></citation></ref>
<ref id="b8-marinedrugs-09-00162"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>XR</given-names></name><name><surname>Tang</surname><given-names>HF</given-names></name><name><surname>Li</surname><given-names>YS</given-names></name><name><surname>Lin</surname><given-names>HW</given-names></name><name><surname>Ma</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title>Sterols from marine bryozoan <italic>Bugula neritina</italic></article-title><source>Biochem Syst Ecol</source><year>2010</year><volume>38</volume><fpage>435</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1016/j.bse.2010.01.016</pub-id></citation></ref>
<ref id="b9-marinedrugs-09-00162"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harte</surname><given-names>RA</given-names></name><name><surname>Yeaman</surname><given-names>SJ</given-names></name><name><surname>McEIhinney</surname><given-names>J</given-names></name><name><surname>Suckling</surname><given-names>CJ</given-names></name><name><surname>Jackson</surname><given-names>B</given-names></name><name><surname>Suckling</surname><given-names>KE</given-names></name></person-group><article-title>Effects of novel synthetic sterol probes on enzymes of cholesterol metabolism in cell-free and cellular systems</article-title><source>Chem Phys Lipids</source><year>1996</year><volume>83</volume><fpage>45</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/0009-3084(96)02593-5</pub-id><pub-id pub-id-type="pmid">8858832</pub-id></citation></ref>
<ref id="b10-marinedrugs-09-00162"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fürst</surname><given-names>A</given-names></name><name><surname>Labler</surname><given-names>L</given-names></name><name><surname>Meier</surname><given-names>W</given-names></name></person-group><article-title>Neue synthesen von 1<italic>α,</italic>25-dihydroxycholesterin</article-title><source>Helv Chim Acta</source><year>1982</year><volume>65</volume><fpage>1499</fpage><lpage>1521</lpage><pub-id pub-id-type="doi">10.1002/hlca.19820650524</pub-id></citation></ref>
<ref id="b11-marinedrugs-09-00162"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koizumi</surname><given-names>N</given-names></name><name><surname>Ishiguro</surname><given-names>M</given-names></name><name><surname>Yasuda</surname><given-names>M</given-names></name><name><surname>Ikekawa</surname><given-names>N</given-names></name></person-group><article-title>Stereoselective introduction of hydroxyl groups into the cholesterol side chain. Preparation of (24<italic>R</italic>)- and (24<italic>S</italic>)-24,25-dihydroxy- and (25<italic>R</italic>)- and (25<italic>S</italic>)-25,26-dihydroxyvitamin D<sub>3</sub> by asymmetric synthesis</article-title><source>J Chem Soc Perkin Trans</source><volume>1</volume><year>1983</year><fpage>1401</fpage><lpage>1410</lpage></citation></ref>
<ref id="b12-marinedrugs-09-00162"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>WK</given-names></name><name><surname>Sumpter</surname><given-names>RM</given-names></name><name><surname>Warren</surname><given-names>JJ</given-names></name><name><surname>Rogers</surname><given-names>PS</given-names></name><name><surname>Ruan</surname><given-names>B</given-names></name><name><surname>Schroepfer</surname><given-names>GJ</given-names><suffix>Jr</suffix></name></person-group><article-title>Analysis of unsaturated C27 sterols by nuclear magnetic resonance spectroscopy</article-title><source>J Lipid Res</source><year>1996</year><volume>37</volume><fpage>1529</fpage><lpage>1555</lpage><pub-id pub-id-type="pmid">8827525</pub-id></citation></ref>
<ref id="b13-marinedrugs-09-00162"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calderon</surname><given-names>GJ</given-names></name><name><surname>Castellanos</surname><given-names>L</given-names></name><name><surname>Duque</surname><given-names>C</given-names></name><name><surname>Echigo</surname><given-names>S</given-names></name><name><surname>Hara</surname><given-names>N</given-names></name><name><surname>Fujimoto</surname><given-names>Y</given-names></name></person-group><article-title>Ophirasterol, a new C31 sterol form the marine sponge <italic>Topsentia ophiraphidites</italic></article-title><source>Steroids</source><year>2004</year><volume>69</volume><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.steroids.2003.11.001</pub-id><pub-id pub-id-type="pmid">15013687</pub-id></citation></ref>
<ref id="b14-marinedrugs-09-00162"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheu</surname><given-names>JH</given-names></name><name><surname>Huang</surname><given-names>SY</given-names></name><name><surname>Duh</surname><given-names>CY</given-names></name></person-group><article-title>Cytotoxic oxygenated desmosterols of the red alge <italic>Galaxaura marginata</italic></article-title><source>J Nat Prod</source><year>1996</year><volume>59</volume><fpage>23</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1021/np960016w</pub-id><pub-id pub-id-type="pmid">8984148</pub-id></citation></ref>
<ref id="b15-marinedrugs-09-00162"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fattorusso</surname><given-names>E</given-names></name><name><surname>Magno</surname><given-names>S</given-names></name><name><surname>Santacroce</surname><given-names>C</given-names></name><name><surname>Sica</surname><given-names>D</given-names></name><name><surname>Impellizzeri</surname><given-names>G</given-names></name><name><surname>Mangiafico</surname><given-names>S</given-names></name><name><surname>Oriente</surname><given-names>G</given-names></name><name><surname>Piattelli</surname><given-names>M</given-names></name><name><surname>Sciuto</surname><given-names>S</given-names></name></person-group><article-title>Sterols of some red algae</article-title><source>Phytochemistry</source><year>1975</year><volume>14</volume><fpage>1579</fpage><lpage>1582</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(75)85354-4</pub-id></citation></ref>
<ref id="b16-marinedrugs-09-00162"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Notaro</surname><given-names>G</given-names></name><name><surname>Piccialli</surname><given-names>V</given-names></name><name><surname>Sica</surname><given-names>D</given-names></name></person-group><article-title>New steroidal hydroxyketones and closely related diols from the marine sponge <italic>Cliona copiosa</italic></article-title><source>J Nat Prod</source><year>1992</year><volume>55</volume><fpage>1588</fpage><lpage>1594</lpage><pub-id pub-id-type="doi">10.1021/np50089a005</pub-id></citation></ref>
<ref id="b17-marinedrugs-09-00162"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kingston</surname><given-names>JF</given-names></name><name><surname>Fallis</surname><given-names>AG</given-names></name></person-group><article-title>Marine natural products: highly functionalized steroids (12<italic>β</italic>-hydroxy-24-norcholesta-1,4,22-trien-3-one and 12<italic>β</italic>-acetoxy-24-norcholesta-1,4,22-trien-3-one) from the sea raspberry <italic>Gersemia rubiformis</italic></article-title><source>Can J Chem</source><year>1982</year><volume>60</volume><fpage>820</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1139/v82-123</pub-id></citation></ref>
<ref id="b18-marinedrugs-09-00162"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riccardis</surname><given-names>F</given-names></name><name><surname>Minale</surname><given-names>L</given-names></name><name><surname>Iorizzi</surname><given-names>M</given-names></name><name><surname>Debitus</surname><given-names>C</given-names></name><name><surname>Levi</surname><given-names>C</given-names></name></person-group><article-title>Marine sterols. Side-chain-oxygenated sterols. Possibly of abiotic origin, from the New Caledonian sponge <italic>Stelodoryx chlorophylla</italic></article-title><source>J Nat Prod</source><year>1993</year><volume>56</volume><fpage>282</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1021/np50092a016</pub-id></citation></ref>
<ref id="b19-marinedrugs-09-00162"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>GQ</given-names></name><name><surname>Deng</surname><given-names>ZW</given-names></name><name><surname>Guan</surname><given-names>HS</given-names></name><name><surname>Guo</surname><given-names>DA</given-names></name><name><surname>Lin</surname><given-names>WH</given-names></name></person-group><article-title>Polyhydroxy sterols from soft coral <italic>Dendronephthya gigantea</italic> from the South Chin Sea</article-title><source>J Chin Mar Drugs</source><year>2004</year><volume>1</volume><fpage>1</fpage><lpage>5</lpage></citation></ref>
<ref id="b20-marinedrugs-09-00162"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>HJ</given-names></name><name><surname>Liu</surname><given-names>XF</given-names></name><name><surname>Chen</surname><given-names>WS</given-names></name><name><surname>Tang</surname><given-names>HF</given-names></name><name><surname>Lin</surname><given-names>HW</given-names></name></person-group><article-title>Oxygenated steroids from marine bryozoan <italic>Biflustra grandicella</italic></article-title><source>Biochem Syst Ecol</source><year>2009</year><volume>37</volume><fpage>686</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1016/j.bse.2009.09.001</pub-id></citation></ref>
<ref id="b21-marinedrugs-09-00162"><label>21.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Supino</surname><given-names>R</given-names></name></person-group><article-title>MTT Assay</article-title><source>The ERGATT/FRAME Data Bank of in Vitro Techniques in Toxicology, Invittox Protocol Number 17</source><publisher-name>INVITTOX</publisher-name><publisher-loc>Nottingham, UK</publisher-loc><year>1990</year></citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures and Tables</title>
<fig id="f1-marinedrugs-09-00162" position="float">
<label>Figure 1.</label>
<caption>
<p>Chemical structures of compounds <bold>1</bold>–<bold>13</bold> from the marine bryozoan <italic>Cryptosula pallasiana.</italic></p></caption>
<graphic xlink:href="marinedrugs-09-00162f1.gif"/></fig>
<fig id="f2-marinedrugs-09-00162" position="float">
<label>Figure 2.</label>
<caption>
<p>Key HMBC and NOESY correlations of compounds <bold>1</bold> and <bold>2</bold>.</p></caption>
<graphic xlink:href="marinedrugs-09-00162f2.gif"/></fig>
<table-wrap id="t1-marinedrugs-09-00162" position="float">
<label>Table 1.</label>
<caption>
<p><sup>1</sup>H NMR (500 MHz) and <sup>13</sup>C NMR (125 MHz) data of compounds <bold>1</bold> and <bold>2</bold> in CDCl<sub>3</sub> <xref ref-type="table-fn" rid="tfn1-marinedrugs-09-00162"><sup>a</sup></xref>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="bottom" rowspan="3"><bold>Position</bold></th>
<th colspan="2" align="center" valign="bottom"><bold>1</bold></th>
<th colspan="2" align="center" valign="bottom"><bold>2</bold></th></tr>
<tr>
<th colspan="4" align="left" valign="top">
<hr/></th></tr>
<tr>
<th align="center" valign="bottom"><bold>δ<sub>c</sub>, mult.</bold></th>
<th align="center" valign="bottom"><bold>δ<sub>H</sub>, (int., mult.,</bold> <bold><italic>J</italic></bold> <bold>in Hz)</bold></th>
<th align="center" valign="bottom"><bold>δ<sub>c</sub>, mult.</bold></th>
<th align="center" valign="bottom"><bold>δ<sub>H</sub>, (int., mult.,</bold> <bold><italic>J</italic></bold> <bold>in Hz)</bold></th></tr></thead>
<tbody>
<tr>
<td align="center" valign="top">1</td>
<td align="center" valign="top">37.4 t</td>
<td align="center" valign="top"><italic>α</italic> 1.84 (1H, m), <italic>β</italic> 1.14 (1H, m)</td>
<td align="center" valign="top">36.9 t</td>
<td align="center" valign="top"><italic>α</italic> 1.82 (1H, m), <italic>β</italic> 1.16 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">2</td>
<td align="center" valign="top">31.8 t</td>
<td align="center" valign="top"><italic>α</italic> 1.83 (1H, m), <italic>β</italic> 1.49 (1H, m)</td>
<td align="center" valign="top">31.6 t</td>
<td align="center" valign="top"><italic>α</italic> 1.84 (1H, m), <italic>β</italic> 1.51 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">3</td>
<td align="center" valign="top">71.9 d</td>
<td align="center" valign="top">3.52 (1H, m)</td>
<td align="center" valign="top">71.6 d</td>
<td align="center" valign="top">3.61 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">4</td>
<td align="center" valign="top">42.4 t</td>
<td align="center" valign="top"><italic>α</italic> 2.28 (1H, m), <italic>β</italic> 2.23 (1H, m)</td>
<td align="center" valign="top">42.5 t</td>
<td align="center" valign="top"><italic>α</italic> 2.33 (1H, m), <italic>β</italic> 2.29 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">5</td>
<td align="center" valign="top">140.9 s</td>
<td align="center" valign="top">–</td>
<td align="center" valign="top">146.2 s</td>
<td align="center" valign="top">–</td></tr>
<tr>
<td align="center" valign="top">6</td>
<td align="center" valign="top">121.8 d</td>
<td align="center" valign="top">5.35 (1H, t, 2.8)</td>
<td align="center" valign="top">120.9 d</td>
<td align="center" valign="top">5.73 (1H, dd, 5.0, 1.7)</td></tr>
<tr>
<td align="center" valign="top">7</td>
<td align="center" valign="top">32.0 t</td>
<td align="center" valign="top"><italic>α</italic> 1.48 (1H, m), <italic>β</italic> 1.97 (1H, m)</td>
<td align="center" valign="top">74.1 d</td>
<td align="center" valign="top">3.27 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">8</td>
<td align="center" valign="top">32.0 d</td>
<td align="center" valign="top">1.46 (1H, m)</td>
<td align="center" valign="top">37.3 d</td>
<td align="center" valign="top">1.50 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">9</td>
<td align="center" valign="top">50.2 d</td>
<td align="center" valign="top">0.93 (1H, m)</td>
<td align="center" valign="top">42.9 d</td>
<td align="center" valign="top">1.31 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">10</td>
<td align="center" valign="top">36.6 s</td>
<td align="center" valign="top">–</td>
<td align="center" valign="top">37.6 s</td>
<td align="center" valign="top">–</td></tr>
<tr>
<td align="center" valign="top">11</td>
<td align="center" valign="top">21.2 t</td>
<td align="center" valign="top"><italic>α</italic> 1.00 (1H, m), <italic>β</italic> 1.47 (1H, m)</td>
<td align="center" valign="top">20.9 t</td>
<td align="center" valign="top"><italic>α</italic> 1.02 (1H, m), <italic>β</italic> 1.49 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">12</td>
<td align="center" valign="top">39.9 t</td>
<td align="center" valign="top"><italic>α</italic> 1.15 (1H, m), <italic>β</italic> 1.99 (1H, m)</td>
<td align="center" valign="top">39.1 t</td>
<td align="center" valign="top"><italic>α</italic> 1.19 (1H, m), <italic>β</italic> 1.94 (1H, dt, 12.6, 3.6)</td></tr>
<tr>
<td align="center" valign="top">13</td>
<td align="center" valign="top">42.5 s</td>
<td align="center" valign="top">–</td>
<td align="center" valign="top">42.2 s</td>
<td align="center" valign="top">–</td></tr>
<tr>
<td align="center" valign="top">14</td>
<td align="center" valign="top">56.9 d</td>
<td align="center" valign="top">0.98 (1H, m)</td>
<td align="center" valign="top">49.3 d</td>
<td align="center" valign="top">1.51 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">15</td>
<td align="center" valign="top">24.5 t</td>
<td align="center" valign="top"><italic>α</italic> 1.59 (1H, m), <italic>β</italic> 1.08 (1H, m)</td>
<td align="center" valign="top">24.4 t</td>
<td align="center" valign="top"><italic>α</italic> 1.59 (1H, m), <italic>β</italic> 1.07 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">16</td>
<td align="center" valign="top">28.4 t</td>
<td align="center" valign="top"><italic>α</italic> 1.84 (1H, m), <italic>β</italic> 1.28 (1H, m)</td>
<td align="center" valign="top">28.8 t</td>
<td align="center" valign="top"><italic>α</italic> 1.74 (1H, m), <italic>β</italic> 1.26 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">17</td>
<td align="center" valign="top">56.0 d</td>
<td align="center" valign="top">1.10 (1H, m)</td>
<td align="center" valign="top">55.8 d</td>
<td align="center" valign="top">1.21 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">18</td>
<td align="center" valign="top">12.1 q</td>
<td align="center" valign="top">0.69 (3H, s)</td>
<td align="center" valign="top">11.8 q</td>
<td align="center" valign="top">0.67 (3H, s)</td></tr>
<tr>
<td align="center" valign="top">19</td>
<td align="center" valign="top">19.5 q</td>
<td align="center" valign="top">1.00 (3H, s)</td>
<td align="center" valign="top">18.4 q</td>
<td align="center" valign="top">0.98 (3H, s)</td></tr>
<tr>
<td align="center" valign="top">20</td>
<td align="center" valign="top">36.2 d</td>
<td align="center" valign="top">1.47 (1H, m)</td>
<td align="center" valign="top">40.3 d</td>
<td align="center" valign="top">2.05 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">21</td>
<td align="center" valign="top">18.9 q</td>
<td align="center" valign="top">0.91 (3H, d, 6.6)</td>
<td align="center" valign="top">21.0 q</td>
<td align="center" valign="top">1.01 (3H, d, 6.6)</td></tr>
<tr>
<td align="center" valign="top">22</td>
<td align="center" valign="top">39.3 t</td>
<td align="center" valign="top">a 2.17 (1H, m), b 1.78 (1H, m)</td>
<td align="center" valign="top">138.4 d</td>
<td align="center" valign="top">5.22 (1H, dd, 15.2, 8.1)</td></tr>
<tr>
<td align="center" valign="top">23</td>
<td align="center" valign="top">128.8 d</td>
<td align="center" valign="top">5.50 (1H, m)</td>
<td align="center" valign="top">126.3 d</td>
<td align="center" valign="top">5.27 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">24</td>
<td align="center" valign="top">136.8 d</td>
<td align="center" valign="top">5.38 (1H, d, 15.8)</td>
<td align="center" valign="top">42.1 t</td>
<td align="center" valign="top">1.83 (2H, m)</td></tr>
<tr>
<td align="center" valign="top">25</td>
<td align="center" valign="top">75.0 s</td>
<td align="center" valign="top">–</td>
<td align="center" valign="top">28.7 d</td>
<td align="center" valign="top">1.58 (1H, m)</td></tr>
<tr>
<td align="center" valign="top">26</td>
<td align="center" valign="top">25.9 q</td>
<td align="center" valign="top">1.25 (3H, s)</td>
<td align="center" valign="top">22.4 q</td>
<td align="center" valign="top">0.86 (3H, d, 1.9)</td></tr>
<tr>
<td align="center" valign="top">27</td>
<td align="center" valign="top">26.3 q</td>
<td align="center" valign="top">1.25 (3H, s)</td>
<td align="center" valign="top">22.5 q</td>
<td align="center" valign="top">0.83 (3H, d, 1.9)</td></tr>
<tr>
<td align="center" valign="top">7−OCH<sub>3</sub></td>
<td align="center" valign="top">–</td>
<td align="center" valign="top">–</td>
<td align="center" valign="top">56.9 q</td>
<td align="center" valign="top">3.35 (3H, s)</td></tr>
<tr>
<td align="center" valign="top">25−OCH<sub>3</sub></td>
<td align="center" valign="top">50.4 q</td>
<td align="center" valign="top">3.15 (3H, s)</td>
<td align="center" valign="top">–</td>
<td align="center" valign="top">–</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-marinedrugs-09-00162">
<label>a</label>
<p>Assignments aided by the DEPT, COSY, TOCSY, HSQC, HMBC, and NOESY experiments.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t2-marinedrugs-09-00162" position="float">
<label>Table 2.</label>
<caption>
<p><sup>13</sup>C NMR data of compounds <bold>3</bold>–<bold>6</bold> (CDCl<sub>3</sub>, 125 MHz) <xref ref-type="table-fn" rid="tfn2-marinedrugs-09-00162"><sup>a</sup></xref>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="bottom" rowspan="3"><bold>Position</bold></th>
<th align="center" valign="bottom"><bold>3</bold></th>
<th align="center" valign="bottom"><bold>4</bold></th>
<th align="center" valign="bottom"><bold>5</bold></th>
<th align="center" valign="bottom"><bold>6</bold></th></tr>
<tr>
<th colspan="4" align="left" valign="top">
<hr/></th></tr>
<tr>
<th align="center" valign="bottom"><bold><italic>δ</italic><sub>C</sub>, mult.</bold></th>
<th align="center" valign="bottom"><bold><italic>δ</italic><sub>C</sub>, mult.</bold></th>
<th align="center" valign="bottom"><bold><italic>δ</italic><sub>C</sub>, mult.</bold></th>
<th align="center" valign="bottom"><bold><italic>δ</italic><sub>C</sub>, mult.</bold></th></tr></thead>
<tbody>
<tr>
<td align="center" valign="top">1</td>
<td align="center" valign="top">36.9 t</td>
<td align="center" valign="top">37.4 t</td>
<td align="center" valign="top">37.4 t</td>
<td align="center" valign="top">37.4 t</td></tr>
<tr>
<td align="center" valign="top">2</td>
<td align="center" valign="top">31.6 t</td>
<td align="center" valign="top">31.8 t</td>
<td align="center" valign="top">31.8 t</td>
<td align="center" valign="top">31.8 t</td></tr>
<tr>
<td align="center" valign="top">3</td>
<td align="center" valign="top">71.6 d</td>
<td align="center" valign="top">71.9 d</td>
<td align="center" valign="top">71.9 d</td>
<td align="center" valign="top">71.9 d</td></tr>
<tr>
<td align="center" valign="top">4</td>
<td align="center" valign="top">42.5 t</td>
<td align="center" valign="top">42.5 t</td>
<td align="center" valign="top">42.4 t</td>
<td align="center" valign="top">42.4 t</td></tr>
<tr>
<td align="center" valign="top">5</td>
<td align="center" valign="top">146.2 s</td>
<td align="center" valign="top">140.9 s</td>
<td align="center" valign="top">140.9 s</td>
<td align="center" valign="top">140.9 s</td></tr>
<tr>
<td align="center" valign="top">6</td>
<td align="center" valign="top">120.9 d</td>
<td align="center" valign="top">121.8 d</td>
<td align="center" valign="top">121.8 d</td>
<td align="center" valign="top">121.9 d</td></tr>
<tr>
<td align="center" valign="top">7</td>
<td align="center" valign="top">74.1 t</td>
<td align="center" valign="top">32.0 t</td>
<td align="center" valign="top">32.0 t</td>
<td align="center" valign="top">32.1 t</td></tr>
<tr>
<td align="center" valign="top">8</td>
<td align="center" valign="top">37.3 d</td>
<td align="center" valign="top">32.1 d</td>
<td align="center" valign="top">32.0 d</td>
<td align="center" valign="top">32.1 d</td></tr>
<tr>
<td align="center" valign="top">9</td>
<td align="center" valign="top">42.9 d</td>
<td align="center" valign="top">50.2 d</td>
<td align="center" valign="top">50.3 d</td>
<td align="center" valign="top">50.3 d</td></tr>
<tr>
<td align="center" valign="top">10</td>
<td align="center" valign="top">37.6 s</td>
<td align="center" valign="top">36.6 s</td>
<td align="center" valign="top">36.7 s</td>
<td align="center" valign="top">36.7 s</td></tr>
<tr>
<td align="center" valign="top">11</td>
<td align="center" valign="top">20.9 t</td>
<td align="center" valign="top">21.2 t</td>
<td align="center" valign="top">21.2 t</td>
<td align="center" valign="top">21.2 t</td></tr>
<tr>
<td align="center" valign="top">12</td>
<td align="center" valign="top">39.2 t</td>
<td align="center" valign="top">39.8 t</td>
<td align="center" valign="top">39.9 t</td>
<td align="center" valign="top">39.9 t</td></tr>
<tr>
<td align="center" valign="top">13</td>
<td align="center" valign="top">42.2 s</td>
<td align="center" valign="top">42.6 s</td>
<td align="center" valign="top">42.5 s</td>
<td align="center" valign="top">42.5 s</td></tr>
<tr>
<td align="center" valign="top">14</td>
<td align="center" valign="top">49.2 d</td>
<td align="center" valign="top">56.8 d</td>
<td align="center" valign="top">56.9 d</td>
<td align="center" valign="top">56.9 d</td></tr>
<tr>
<td align="center" valign="top">15</td>
<td align="center" valign="top">24.4 t</td>
<td align="center" valign="top">24.4 t</td>
<td align="center" valign="top">24.4 t</td>
<td align="center" valign="top">24.4 t</td></tr>
<tr>
<td align="center" valign="top">16</td>
<td align="center" valign="top">28.8 t</td>
<td align="center" valign="top">28.5 t</td>
<td align="center" valign="top">28.3 t</td>
<td align="center" valign="top">28.4 t</td></tr>
<tr>
<td align="center" valign="top">17</td>
<td align="center" valign="top">55.9 d</td>
<td align="center" valign="top">55.9 d</td>
<td align="center" valign="top">56.0 d</td>
<td align="center" valign="top">56.0 d</td></tr>
<tr>
<td align="center" valign="top">18</td>
<td align="center" valign="top">11.6 q</td>
<td align="center" valign="top">12.0 q</td>
<td align="center" valign="top">12.0 q</td>
<td align="center" valign="top">12.0 q</td></tr>
<tr>
<td align="center" valign="top">19</td>
<td align="center" valign="top">18.4 q</td>
<td align="center" valign="top">19.5 q</td>
<td align="center" valign="top">19.8 q</td>
<td align="center" valign="top">19.6 q</td></tr>
<tr>
<td align="center" valign="top">20</td>
<td align="center" valign="top">36.0 d</td>
<td align="center" valign="top">36.0 d</td>
<td align="center" valign="top">35.7 d</td>
<td align="center" valign="top">35.7 d</td></tr>
<tr>
<td align="center" valign="top">21</td>
<td align="center" valign="top">18.9 q</td>
<td align="center" valign="top">19.2 q</td>
<td align="center" valign="top">18.9 q</td>
<td align="center" valign="top">18.9 q</td></tr>
<tr>
<td align="center" valign="top">22</td>
<td align="center" valign="top">36.3 t</td>
<td align="center" valign="top">39.5 t</td>
<td align="center" valign="top">31.8 t</td>
<td align="center" valign="top">31.8 t</td></tr>
<tr>
<td align="center" valign="top">23</td>
<td align="center" valign="top">23.9 t</td>
<td align="center" valign="top">147.6 d</td>
<td align="center" valign="top">31.4 t</td>
<td align="center" valign="top">31.5 t</td></tr>
<tr>
<td align="center" valign="top">24</td>
<td align="center" valign="top">39.7 t</td>
<td align="center" valign="top">132.8 d</td>
<td align="center" valign="top">76.9 d</td>
<td align="center" valign="top">76.5 d</td></tr>
<tr>
<td align="center" valign="top">25</td>
<td align="center" valign="top">28.2 d</td>
<td align="center" valign="top">198.7 s</td>
<td align="center" valign="top">147.6 d</td>
<td align="center" valign="top">147.9 d</td></tr>
<tr>
<td align="center" valign="top">26</td>
<td align="center" valign="top">22.7 q</td>
<td align="center" valign="top">27.1 q</td>
<td align="center" valign="top">111.5 t</td>
<td align="center" valign="top">111.0 t</td></tr>
<tr>
<td align="center" valign="top">27</td>
<td align="center" valign="top">23.0 q</td>
<td align="center" valign="top">–</td>
<td align="center" valign="top">17.4 q</td>
<td align="center" valign="top">17.8 q</td></tr>
<tr>
<td align="center" valign="top">7−OCH<sub>3</sub></td>
<td align="center" valign="top">56.9 q</td>
<td align="center" valign="top">–</td>
<td align="center" valign="top">–</td>
<td align="center" valign="top">–</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn2-marinedrugs-09-00162">
<label>a</label>
<p>Assignments aided by the DEPT, COSY, TOCSY, HSQC, HMBC, and NOESY experiments.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t3-marinedrugs-09-00162" position="float">
<label>Table 3.</label>
<caption>
<p>Cytotoxic activities of compounds <bold>1</bold>–<bold>4</bold>, <bold>7</bold> and <bold>10</bold>–<bold>13</bold> on HL-60 tumor cells <xref ref-type="table-fn" rid="tfn3-marinedrugs-09-00162"><sup>a</sup></xref>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="bottom"><bold>Compound</bold></th>
<th align="center" valign="bottom"><bold>IC<sub>50</sub></bold> <bold>(μg/mL)</bold></th>
<th align="center" valign="bottom"><bold>Compound</bold></th>
<th align="center" valign="bottom"><bold>IC<sub>50</sub></bold> <bold>(μg/mL)</bold></th></tr></thead>
<tbody>
<tr>
<td align="center" valign="top"><bold>1</bold></td>
<td align="center" valign="top">17.91</td>
<td align="center" valign="top"><bold>10</bold></td>
<td align="center" valign="top">15.12</td></tr>
<tr>
<td align="center" valign="top"><bold>2</bold></td>
<td align="center" valign="top">21.30</td>
<td align="center" valign="top"><bold>11</bold></td>
<td align="center" valign="top">14.73</td></tr>
<tr>
<td align="center" valign="top"><bold>3</bold></td>
<td align="center" valign="top">22.11</td>
<td align="center" valign="top"><bold>12</bold></td>
<td align="center" valign="top">NA</td></tr>
<tr>
<td align="center" valign="top"><bold>4</bold></td>
<td align="center" valign="top">15.05</td>
<td align="center" valign="top"><bold>13</bold></td>
<td align="center" valign="top">NA</td></tr>
<tr>
<td align="center" valign="top"><bold>7</bold></td>
<td align="center" valign="top">18.28</td>
<td align="center" valign="top">Adriamycin</td>
<td align="center" valign="top">2.50</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn3-marinedrugs-09-00162">
<label>a</label>
<p>IC<sub>50</sub>: 50% inhibitory concentration, HL-60: human myeloid leukemia cell line, NA: no activity.</p></fn></table-wrap-foot></table-wrap></sec></back></article>
